Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 6/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 4/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | ALPI | P09923 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL675061 | 0.83 | CA4 (0.43) | LTA4HPPARGALDH1A1TSHRMEN1 | |
| SCHEMBL11125484 | 0.81 | TDP1 (0.48) | ALDH1A1TSHRPPARALMNAABCB11 | |
| Fluoride SCHEMBL5185114 | 0.81 | CA4 (0.42) | LTA4HPPARGALDH1A1TSHRMEN1 | |
| SCHEMBL2364594 | 0.79 | PDK1 (0.35) | PPARGALDH1A1MEN1GAAKMT2A | |
| SCHEMBL10447796 | 0.79 | LTA4H (0.42) | LTA4HPPARGTSHRPPARAALPL | |
| SCHEMBL17079111 | 0.79 | LTA4H (0.42) | LTA4HPPARGTSHRPPARAALPL | |
| SCHEMBL9784314 | 0.79 | LTA4H (0.42) | LTA4HPPARGTSHRPPARAALPL | |
| SCHEMBL118174 | 0.78 | CA4 (0.43) | LTA4HPPARGALDH1A1TSHRMEN1 | |
| SCHEMBL11147766 | 0.78 | PPARG (0.47) | PPARGGAAPPARANPC1RAB9A | |
| SCHEMBL15509337 | 0.78 | LTA4H (0.41) | LTA4HPPARGTSHRPPARAALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117645531-A | Preparation method of p-tert-octyl phenoxy ethoxy ethyl chloride | 扬州市普林斯医药科技有限公司 | 2024-03-05 | — | — | CN | disclosed |
| EP-3569591-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SABIC Global Technologies B.V. (NL) | 2019-11-20 | — | — | EP | disclosed |
| US-20190337895-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2019-11-07 | — | — | US | disclosed |
| US-10435368-B2 | High heat monomers and methods of use thereof | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-10-08 | — | — | US | disclosed |
| EP-3172188-B1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2019-09-04 | — | — | EP | disclosed |
| US-20170166528-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2017-06-15 | — | — | US | disclosed |
| EP-3172188-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SABIC Global Technologies B.V. (NL) | 2017-05-31 | — | — | EP | disclosed |
| WO-2016014629-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-01-28 | — | — | WO | disclosed |
| US-20060008807-A1 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample | VERIDEX, LLC | 2006-01-12 | — | — | US | disclosed |
| EP-1438419-A2 | MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE | IMMUNIVEST CORPORATION (US) | 2004-07-21 | — | — | EP | disclosed |
| EP-1438398-A2 | MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE | IMMUNIVEST CORPORATION (US) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003035895-A2 | MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE | IMMUNIVEST CORPORATION (US) | 2003-05-01 | — | — | WO | disclosed |
| WO-2003035894-A2 | MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE | IMMUNIVEST CORPORATION (US) | 2003-05-01 | — | — | WO | disclosed |
| EP-1178973-A2 | NOVEL COMPOUNDS, THEIR USE AND PREPARATION | Pharmacia AB (SE) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000076984-A2 | NOVEL COMPOUNDS, THEIR USE AND PREPARATION | BIOVITRUM AB (SE) | 2000-12-21 | — | — | WO | disclosed |
| US-4072528-A | Oxygen barrier layers for photopolymerizable elements | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-02-07 | — | — | US | disclosed |
| US-4072527-A | Oxygen barrier layers for photopolymerizable elements | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190337895-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | HSP90AA1, HSP90AB1, HSPBP1 | LTA4H 2343/4885PPARG 3276/4885ALDH1A1 821/4885 |
| US-20170166528-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | HSP90AA1, HSP90AB1, HSPBP1 | LTA4H 2343/4885PPARG 3276/4885ALDH1A1 821/4885 |
| US-10435368-B2 | High heat monomers and methods of use thereof | HSP90AA1, HSP90AB1, HSPBP1 | LTA4H 2343/4885PPARG 3276/4885ALDH1A1 821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.